Survival analysis i a population with breast cancer and its pronostic factors
230 months-follow up in 1.311 women
Abstract
A descriptive analysis was conducted in the Breast Diagnostic Center (Centro de Diagnóstico Mamaria, CENDIMA, Uruguay) during 230 months when description, survival and disease-free survival were analyzed in 1.311 treated women with breast cancer, in correlation to the prognostic factors for breast cancer.
For this population, ganglia status and stage were the parameters of highest prognostic value in relation to disease-free survival; ganglia status and final histologic score were the main variables considering global survival.
Final data was comparable to international literature.
References
2) Vasallo JA, Barrios E. II Atlas de Mortalidad por Cáncer en el Uruguay- Comparación de 2 quinquenios 1989-1993 y 1994-1998. Montevideo: Comisión Honoraria de Lucha contra el Cáncer, 1999.
3) Vasallo JA, Barrios E, De-Stefani E, Ronco A. II Atlas de Incidencia del Cáncer en Uruguay 1996-1997. Montevideo: Comisión Honoraria de Lucha contra el Cáncer, 2001.
4) Sabini G, Delgado L, Suárez L, Musé IM. Cáncer de mama localizado. In: Musé I, Viola A, Sabini G, eds. Aspectos Prácticos de la Clínica Oncológica. Montevideo: Sudamericana, 2004: 235-50.
5) Fisher B, Osborne K, Margolese R, Bloomer W. Neoplasms of the breast. In: Holland J, Frei E, Bast R, Kufe D, Morton D, Weichselbaum R, Cancer Medicine (3rd ed) Philadelphia: Lea & Febiger, 1993: 1706-74.
6) Musé I, Viola-Alles A. Cáncer de Mama. Montevideo: U.R. 2 vol. 1981.
7) Artagaveytia N, Raymondo S, Román E, Delgado L, Alonso I, Alonso O, et al. Receptores hormonales en el CM y su relación con algunos parámetros de la enfermedad. Arch Med Interna (Montevideo) 1997; 20(suppl.): 53.
8) Bonadonna G, Hortobagyi G, Gianni M. Textbook of breast cancer: a clinical guide to therapy. London: Dunitz, 1997.
9) Nabholtz J, Tonkin K, Aapro M, Buzdar A. Breast cancer management: application of evidence to patient care. London: Dunitz, 2000.
10) Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
11) Savage IR. Contributions to the theory of rank order statistics - the two sample case. Ann Math Stat 1956 27: 590-615.
12) Cox DR. Regression models and life tables (with discussion). J.R. Stat Soc B 1972; 34: 187-220.
13) Ministerio de Salud Pública. Ordenanza Nº 752; ref: 1439/96. Montevideo: MSP, 1996.
14) Henderson B, Ross R, Bernstein L. Estrogens as a cause of human cancer. The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1988; 48: 246-53.
15) Krygier G. Tratamiento sistémico del cáncer de mama. In: Vázquez T, Santini A, editores: Los cánceres más frecuentes. Tomo 2. Montevideo: Oficina del Libro AEM, 2000: 103-19.
16) Schneeweiss A, Katretchko J, Sinn H, Unnebrink K, Rudlowski C, Geberth M, et al. Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy. Anticancer Drugs 2004:15(2): 127-35.
17) Viola A, Musé I, Vasallo J, Pees G, Pacheco H, Sabini G, et al. Sobrevida del cáncer de mama en poblaciones mutuales y hospitalarias. Cir Urug 1987; 57(1): 1-5.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.